Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19
Xiangbo Shen,
Eryue Qiu,
Zhao Liu
et al.
Abstract:Objectives:
To evaluate the effectiveness and safety of rivaroxaban anticoagulation in COVID-19 patients.
Methods:
PubMed, Embase, Cochrane Library electronic databases, and ClinicalTrials.gov were searched to identify all relevant randomized controlled trial studies from December 2019 to July 2023.
Results:
A total of 6 randomized controlled trials, which included a total of 3323 patients, were considered for evaluation. Overall, short-term … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.